TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
The Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for discovering light-gated ion channels and developing optogenetics. This technique allows scientists to control specific nerve cells with light, revolutionizing neuroscience research. The award highlights the method’s role in understanding brain circuits and potential treatments for neurological conditions.
The Nobel Prize in Physiology or Medicine was awarded Monday to Karl Deisseroth, Peter Hegemann, and Georg Nagel for their groundbreaking work in optogenetics. The Nobel Assembly recognized their discovery of light-gated ion channels and the development of a method that uses light to control specific nerve cells. This tool has transformed neuroscience by allowing researchers to precisely manipulate brain circuits in living organisms, offering new insights into how the brain functions and how diseases disrupt it.
The prize honors the discovery that certain proteins, originally found in green algae, can be used to make nerve cells sensitive to light. Hegemann and Nagel identified a protein that opens a channel when exposed to blue light, creating an electrical impulse. Deisseroth later adapted this gene to create a light-controlled switch for neurons in the brains of living mice. This allowed scientists to turn specific neural pathways on and off with high precision.
The technique, known as optogenetics, is now used in laboratories worldwide. It has enabled researchers to map the pathways involved in behavior and disease. According to the Nobel Assembly, the method has opened a new era in neuroscience by providing a way to dissect the brain’s complex circuitry. The tool is not just for observation but for active control, allowing scientists to test causal relationships between specific neurons and behaviors.
Deisseroth, a professor at Stanford University, described the shift in perspective: “People usually think about light as a way of collecting information to observe things. But this is the opposite of that. This is using light to control things, to make things happen, and to do it in a very precise way.” The technique has already been applied in early-stage trials for conditions such as retinitis pigmentosa, a genetic form of vision loss.
Impact on Neurological Disease Research
The award underscores the profound impact of optogenetics on the understanding of brain disorders. Abdel El Manira, a member of the Nobel Assembly, stated that the technique has helped reveal how specific brain circuits are disrupted in conditions such as blindness, depression, addiction, and dementia. By isolating and controlling specific neurons, researchers can identify which circuits are responsible for symptoms, moving beyond correlation to causation.
This precision is critical for developing targeted therapies. While optogenetics itself is primarily a research tool, the knowledge gained from it informs the development of treatments for conditions like autism and schizophrenia. The ability to manipulate neural activity with millisecond precision allows for a deeper understanding of the mechanisms underlying these complex disorders, potentially leading to more effective interventions in the future.
As an affiliate, we earn on qualifying purchases.
From Algae to Human Brain Science
The journey of optogenetics began with the study of Chlamydomonas, a single-celled green algae that swims toward light. Peter Hegemann and Georg Nagel discovered that a specific protein in the algae, called channelrhodopsin, acts as a light-gated ion channel. When illuminated, this protein allows ions to flow into the cell, generating an electrical signal.
Karl Deisseroth recognized the potential of applying this biological mechanism to neuroscience. He inserted the gene for channelrhodopsin into the neurons of mice, creating cells that could be activated by light. He also developed optical fibers to deliver light deep into the brain. This collaboration between biological discovery and engineering innovation created a versatile tool that has since been adapted for various species and brain regions, becoming a standard method in modern neuroscience labs.
“People usually think about light as a way of collecting information to observe things. But this is the opposite of that. This is using light to control things, to make things happen, and to do it in a very precise way.”
— Karl Deisseroth, Nobel laureate
Limits of Current Clinical Application
While optogenetics is a powerful research tool, its direct application in human medicine remains limited. Currently, it is mostly used in animal models to understand disease mechanisms. Direct optogenetics is being tested for retinitis pigmentosa, but widespread therapeutic use faces challenges, including the need for genetic modification of cells and the delivery of light to specific brain areas. It is not yet clear how quickly these technical hurdles will be overcome for broader neurological conditions.
Nobel Week Schedule and Future Research
The medicine prize marks the start of Nobel Week. The Physics Prize is scheduled for Tuesday, followed by Chemistry on Wednesday and Literature on Thursday. The Peace Prize will be awarded on Friday, and the Economic Sciences prize on October 12. In research, scientists will continue to refine optogenetic methods, exploring new light-sensitive proteins and improved delivery techniques to enhance precision and safety in future clinical trials.
Key Questions
What is optogenetics?
Optogenetics is a biological technique that involves the use of light to control cells in living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. It allows researchers to turn specific nerve cells on or off with precise timing.
Who won the 2025 Nobel Prize in Medicine?
The prize was awarded to Karl Deisseroth (Stanford University), Peter Hegemann (Humboldt University), and Georg Nagel (formerly University of Würzburg) for their work on light-gated ion channels and optogenetics.
How does optogenetics help treat diseases?
While primarily a research tool, optogenetics helps identify which brain circuits are involved in diseases like depression or addiction. This knowledge guides the development of targeted treatments, such as deep brain stimulation or gene therapies, though direct optogenetic treatment in humans is still in early stages.
What is the prize money?
The Nobel Prize in Physiology or Medicine comes with a cash award of 12 million Swedish kronor (approximately $1.2 million), shared among the laureates.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
